Skip to main content


Collaborative Advancement of Recovery Excellence

Translating science to service, powered by Gloo
Clinical Challenges
Cognitive behavioral therapy was found to reduce symptoms of insomnia among young adult binge drinkers in a pilot study recently released by the University of Missouri School of Medicine and published in the Sleep Research Society journal.
Early data from Hazelden Betty Ford Foundation suggests that virtual intensive outpatient services have been as effective as on-site IOP treatment, a promising development as providers have moved many operations to virtual platforms as a result of the COVID-19 pandemic.
Universal Health Services and Eleos Health, a behavioral health tech firm, have announced the launch of a six-week pilot program for clinical decision-support software to analyze patient experiences and treatment outcomes in Nashville.
Despite documented efficacy, adoption of medication-assisted treatment among providers remains slow across the U.S., largely because of a fractured treatment system.
A national study of 2,619 licensed psychologists conducted by researchers at Virginia Commonwealth University found that their clinical work conducted via telehealth platforms has increased 12-fold since the start of the COVID-19 pandemic.
Gloo Executive Director Steve Millette joins the BHE Podcast to discuss his organization’s partnership with the Psychiatry & Behavioral Health Learning Network to create the Collaborative Advancement of Recovery Excellence, a recovery research-focused resource, and a weekly Director Poll that…
Clinical Challenges
Half of clinicians who are waivered to prescribe buprenorphine for the treatment of opioid use disorder have actually done so, and a majority are prescribing the medication for a number of patients that is well below the limit for which they are waivered, according to a new study.
A study released by Milliman illustrates a sizable disconnect between the degree to which patients with behavioral health conditions are driving total healthcare costs in the U.S., while spending on behavioral health treatment remains comparatively slim.
A survey of behavioral healthcare providers conducted by the National Council and Qualifacts suggests the telehealth services launched in response to COVID-19 are going to become a fixture post-pandemic, but structural changes are needed for long-term financial viability.
Medication Treatments
A recently published study of 2017 data found that 60% of residential treatment centers in the U.S. offered zero medications for opioid use disorder and just 15% of patients had an MOUD as part of their treatment plan.
Back to Top